Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges

Bioconjug Chem. 2015 Jul 15;26(7):1198-211. doi: 10.1021/acs.bioconjchem.5b00031. Epub 2015 Feb 13.

Abstract

Dendrimers are three-dimensional macromolecular structures originating from a central core molecule and surrounded by successive addition of branching layers (generation). These structures exhibit a high degree of molecular uniformity, narrow molecular weight distribution, tunable size and shape characteristics, as well as multivalency. Collectively, these physicochemical characteristics together with advancements in design of biodegradable backbones have conferred many applications to dendrimers in formulation science and nanopharmaceutical developments. These have included the use of dendrimers as pro-drugs and vehicles for solubilization, encapsulation, complexation, delivery, and site-specific targeting of small-molecule drugs, biopharmaceuticals, and contrast agents. We briefly review these advances, paying particular attention to attributes that make dendrimers versatile for drug formulation as well as challenging issues surrounding the future development of dendrimer-based medicines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacokinetics
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / toxicity
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy
  • Dendrimers / chemistry*
  • Dendrimers / pharmacokinetics
  • Dendrimers / pharmacology
  • Dendrimers / toxicity
  • Drug Carriers / chemistry*
  • Drug Carriers / pharmacokinetics
  • Drug Carriers / toxicity
  • Drug Delivery Systems* / methods
  • Humans
  • Tissue Engineering / methods
  • Transfection* / methods
  • Virus Diseases / drug therapy
  • Viruses / drug effects

Substances

  • Anti-Infective Agents
  • Dendrimers
  • Drug Carriers